We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current GLUC market cap is 6.65M. The company's latest EPS is USD -0.0387 and P/E is -10.08.
Year End 31 December 2022 | 2022 |
---|---|
USD (US$) | |
Total Revenue | 1.07M |
Operating Income | -562k |
Net Income | -658k |
Year End 31 December 2022 | 2022 |
---|---|
USD (US$) | |
Total Assets | 598k |
Total Liabilities | 21k |
Total Equity | 577k |
Year End 31 December 2022 | 2022 |
---|---|
USD (US$) | |
Operating | -390k |
Investing | N/A |
Financing | -96k |
Market Cap | 6.65M |
Price to Earnings Ratio | -10.08 |
Price to Sales Ratio | 6.18 |
Price to Cash Ratio | 25 |
Price to Book Ratio | 11.5 |
Dividend Yield | - |
Shares Outstanding | 17.01M |
Average Volume (1 week) | 6.86k |
Average Volume (1 Month) | 14.08k |
52 Week Change | 10.89% |
52 Week High | 0.9001 |
52 Week Low | 0.091 |
Spread (Intraday) | 0.07 (15.62%) |
Company Name | Glucose Health Inc (PK) |
Address |
1201 n. market street wilmington, delaware 19801 |
Website | https://www.glucosehealthinc.com |
Industry | medicinal chems,botanicl pds (2833) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions